Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
8 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Adiponectin has different mechanisms in type 1 and type 2 diabetes with C-peptide link.
Clin Invest Med. 2009 Aug 1;32(4):E271-9. doi: 10.25011/cim.v32i4.6618.
Clin Invest Med. 2009.
PMID: 19640330
SYSTEMIC INFECTION WITH SINGLE OR MULTI-ORGAN DAMAGE CAUSED BY INADEQUATELY MANAGED CHRONIC WOUNDS: A CASE SERIES.
Delalić Đ, Roher R, Mileta D, Prkačin I.
Delalić Đ, et al. Among authors: mileta d.
Acta Clin Croat. 2022 Jun;61(Suppl 1):49-52. doi: 10.20471/acc.2022.61.s1.08.
Acta Clin Croat. 2022.
PMID: 36304799
Free PMC article.
Item in Clipboard
Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab.
Hagström E, Steg PG, Szarek M, Bhatt DL, Bittner VA, Danchin N, Diaz R, Goodman SG, Harrington RA, Jukema JW, Liberopoulos E, Marx N, McGinniss J, Manvelian G, Pordy R, Scemama M, White HD, Zeiher AM, Schwartz GG; ODYSSEY OUTCOMES Investigators.
Hagström E, et al.
Circulation. 2022 Aug 30;146(9):657-672. doi: 10.1161/CIRCULATIONAHA.121.057807. Epub 2022 Jun 30.
Circulation. 2022.
PMID: 35770629
Free PMC article.
Clinical Trial.
Item in Clipboard
Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol.
Schwartz GG, Szarek M, Bittner VA, Diaz R, Goodman SG, Jukema JW, Landmesser U, López-Jaramillo P, Manvelian G, Pordy R, Scemama M, Sinnaeve PR, White HD, Gabriel Steg P; ODYSSEY Outcomes Committees and Investigators.
Schwartz GG, et al.
J Am Coll Cardiol. 2021 Aug 3;78(5):421-433. doi: 10.1016/j.jacc.2021.04.102.
J Am Coll Cardiol. 2021.
PMID: 34325831
Free PMC article.
Clinical Trial.
Item in Clipboard
Relation of Lipoprotein(a) Levels to Incident Type 2 Diabetes and Modification by Alirocumab Treatment.
Schwartz GG, Szarek M, Bittner VA, Bhatt DL, Diaz R, Goodman SG, Jukema JW, Loy M, Manvelian G, Pordy R, White HD, Steg PG; ODYSSEY OUTCOMES Committees and Investigators.
Schwartz GG, et al.
Diabetes Care. 2021 May;44(5):1219-1227. doi: 10.2337/dc20-2842. Epub 2021 Mar 15.
Diabetes Care. 2021.
PMID: 33722880
Free PMC article.
Item in Clipboard
Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial.
Ray KK, Colhoun HM, Szarek M, Baccara-Dinet M, Bhatt DL, Bittner VA, Budaj AJ, Diaz R, Goodman SG, Hanotin C, Harrington RA, Jukema JW, Loizeau V, Lopes RD, Moryusef A, Murin J, Pordy R, Ristic AD, Roe MT, Tuñón J, White HD, Zeiher AM, Schwartz GG, Steg PG; ODYSSEY OUTCOMES Committees and Investigators.
Ray KK, et al.
Lancet Diabetes Endocrinol. 2019 Aug;7(8):618-628. doi: 10.1016/S2213-8587(19)30158-5. Epub 2019 Jul 1.
Lancet Diabetes Endocrinol. 2019.
PMID: 31272931
Free article.
Clinical Trial.
Item in Clipboard
Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome.
Schwartz GG, Steg PG, Szarek M, Bhatt DL, Bittner VA, Diaz R, Edelberg JM, Goodman SG, Hanotin C, Harrington RA, Jukema JW, Lecorps G, Mahaffey KW, Moryusef A, Pordy R, Quintero K, Roe MT, Sasiela WJ, Tamby JF, Tricoci P, White HD, Zeiher AM; ODYSSEY OUTCOMES Committees and Investigators.
Schwartz GG, et al.
N Engl J Med. 2018 Nov 29;379(22):2097-2107. doi: 10.1056/NEJMoa1801174. Epub 2018 Nov 7.
N Engl J Med. 2018.
PMID: 30403574
Free article.
Clinical Trial.
Item in Clipboard
Genealogical study of myotonic dystrophy in Istria (Croatia).
Medica I, Logar N, Mileta DL, Peterlin B.
Medica I, et al. Among authors: mileta dl.
Ann Genet. 2004 Apr-Jun;47(2):139-46. doi: 10.1016/j.anngen.2003.08.026.
Ann Genet. 2004.
PMID: 15183746
Item in Clipboard
Cite
Cite